EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Burden of haematological malignancies among children, adolescents and young adults: Global and high‐income region insights from the GBD 2021 study

Shujuan Xu, Baihua Yang, Xinxin Liu, Zhenshu Xu, Ping Weng iD

British Journal of Haematology · 2026-02 · 208 (2) · 534-544

DOI: 10.1111/bjh.70265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 25.11.2025. Verfasst von Shujuan Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Institute of Hematology, Fujian Province Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Hematologic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Startup Fund for scientific research, Fujian Medical University, National Key Clinical Specialty Discipline Construction Program, Fujian Provincial Clinical Research Center for Hematological Malignancies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study provides a comprehensive assessment of haematological malignancies among children, adolescents and young adults aged 0–24 years, using data from the Global Burden of Disease 2021 across 204 countries from 1990 to 2021. We found that global incidence and prevalence remained relatively stable, with approximately 150 000 new cases and over one million prevalent cases in 2021, while mortality and disability‐adjusted life year (DALY) rates declined markedly. Leukaemia was the leading contributor to incidence, deaths, and DALYs, although decreases were observed across most subtypes. Age‐ and sex‐specific analyses revealed higher burdens in males and a pronounced peak in the

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsHumansAdolescentChildMaleFemaleYoung AdultChild, PreschoolInfantGlobal Burden of DiseaseInfant, NewbornGlobal HealthIncidenceDisability-Adjusted Life YearsPrevalenceAdult

Stichwörter der Autor:innen

Global Burden of Disease (GBD) 2021children, adolescents and young adults (0–24 years)haematological malignancieshealth inequality analysishigh‐income regions

Autor:innen und Institutionen

  • Fujian Institute of Hematology, Fujian Province Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
  • Department of Hematology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an City, Shandong, China.

ORCID-Profile: Ping Weng

Förderung

  • Startup Fund for scientific research, Fujian Medical University
  • National Key Clinical Specialty Discipline Construction Program
  • Fujian Provincial Clinical Research Center for Hematological Malignancies
  • National Key Clinical Specialty Discipline Construction Program of China

Zitieren

APA

Xu, S., Yang, B., Liu, X., Xu, Z., & Weng, P. (2026). Burden of haematological malignancies among children, adolescents and young adults: Global and high‐income region insights from the GBD 2021 study. British Journal of Haematology, 208(2), 534-544. https://doi.org/10.1111/bjh.70265

Vancouver

Xu S, Yang B, Liu X, Xu Z, Weng P. Burden of haematological malignancies among children, adolescents and young adults: Global and high‐income region insights from the GBD 2021 study. British Journal of Haematology. 2026;208(2):534-544. doi:10.1111/bjh.70265

BibTeX
@article{Xu2026,
  author = {Xu, Shujuan and Yang, Baihua and Liu, Xinxin and Xu, Zhenshu and Weng, Ping},
  title = {Burden of haematological malignancies among children, adolescents and young adults: Global and high‐income region insights from the GBD 2021 study},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {208},
  number = {2},
  pages = {534--544},
  doi = {10.1111/bjh.70265}
}
Kostenlos starten →